KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Rigel Pharmaceuticals (RIGL) over the last 9 years, with Sep 2025 value amounting to $19.2 million.

  • Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) rose 8.54% to $19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.2 million, marking a year-over-year increase of 8.54%. This contributed to the annual value of $17.7 million for FY2024, which is 1.64% up from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $19.2 million, which was up 5.44% from $18.2 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' Shares Outstanding (Diluted Average)'s 5-year high stood at $176.5 million during Q3 2021, with a 5-year trough of $17.0 million in Q4 2022.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $17.6 million (2024), whereas its average is $32.0 million.
  • In the last 5 years, Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) crashed by 90.00% in 2022 and then increased by 8.54% in 2025.
  • Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $170.5 million in 2021, then plummeted by 90.00% to $17.0 million in 2022, then rose by 2.06% to $17.4 million in 2023, then increased by 1.64% to $17.7 million in 2024, then rose by 8.54% to $19.2 million in 2025.
  • Its last three reported values are $19.2 million in Q3 2025, $18.2 million for Q2 2025, and $18.2 million during Q1 2025.